Well there's the answer
"CEO Sam Hupert Mayo is arguably one of the most recognised medical institutions in the US, if not the world, so winning this deal will most likely have a positive impact on our sales pipeline, exactly how much is hard to predict. However, we expect that most large institutions will at least consider us when putting out an RFP, which hopefully will translate to us getting to the starting line more often. Then to some degree it’s up to us, but having another key reference site will mean a lot, particularly to the academic/teaching hospitals and large health systems. It will confirm to them that Visage can handle big and complex environments such as theirs, which I believe will have a further positive impact on the pipeline"
Well there's the answer "CEO Sam Hupert Mayo is arguably one of...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$221.75 |
Change
7.130(3.32%) |
Mkt cap ! $17.90B | |||
| Open | High | Low | Value | Volume |
| $216.99 | $224.65 | $215.12 | $38.21M | 172.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 103 | $221.64 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $221.81 | 426 | 1 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| PME (ASX) Chart |
